SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000875320-13-000013
Filing Date
2013-04-04
Accepted
2013-04-04 17:23:13
Documents
10
Period of Report
2013-05-08
Effectiveness Date
2013-04-04

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2013proxy013013.htm DEF 14A 1854005
3 a2013proxy013013image3.gif GRAPHIC 2203
4 chart1.jpg GRAPHIC 14876
5 chart2.jpg GRAPHIC 46117
6 cover.jpg GRAPHIC 3106356
7 khsig.jpg GRAPHIC 39795
8 proxycard1.jpg GRAPHIC 1071126
9 proxycard2.jpg GRAPHIC 1023644
10 vertexlogo.jpg GRAPHIC 28782
11 vertexlogoa01.jpg GRAPHIC 28782
  Complete submission text file 0000875320-13-000013.txt   9243326
Mailing Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6173416100
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-19319 | Film No.: 13743860
SIC: 2834 Pharmaceutical Preparations